Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Thumb-1 allosteric site is a regulatory pocket located on the thumb domain of the Hepatitis C virus (HCV) nonstructural protein 5B (NS5B), which functions as the RNA-dependent RNA polymerase (RdRp) responsible for replicating the viral genome (Tomei et al., 2005, PubMed: 16135246). This site is a primary target for non-nucleoside inhibitors (NNIs), which bind to the enzyme at a location distal to the catalytic active site. Binding at the Thumb-1 site stabilizes the polymerase in an inactive conformation, preventing the essential structural transition from the initiation phase to the elongation phase of RNA synthesis (Beaulieu, 2009, PubMed: 19450130). This mechanism effectively blocks the production of new viral RNA strands, making it a key component in direct-acting antiviral (DAA) strategies for treating chronic Hepatitis C. While potent, inhibitors targeting this site often face challenges such as a low genetic barrier to resistance and high specificity for certain HCV genotypes, particularly genotype 1 (Di Marco et al., 2005, PubMed: 15939857). Consequently, these drugs are typically developed for use in combination therapy to ensure sustained virologic response and prevent the selection of resistant viral variants.
Non-nucleoside inhibition (NNI) through binding to the Thumb-1 allosteric pocket, which stabilizes the polymerase in an inactive conformation and prevents the transition from the initiation to the elongation phase of RNA synthesis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus nonstructural protein 5B RNA-dependent RNA polymerase (Thumb-1 allosteric site) (HCV NS5B Thumb-1 site).